← FDA DRUG APPROVALS

FDA NDA · NDA022193

NAVSTEL

Sponsor: ALCON PHARMS LTD

APPLICATION
NDA022193
TYPE
NDA
ORIGINAL APPROVAL
2008-07-24
LATEST ACTION
2008-07-24
ROUTE
IRRIGATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

NAVSTELDiscontinued
CALCIUM CHLORIDE 0.154MG/ML, DEXTROSE 0.92MG/ML, MAGNESIUM CHLORIDE 0.2MG/ML, OXIGLUTATIONE 0.184MG/ML, POTASSIUM CHLORIDE 0.38MG/ML, SODIUM BICARBONATE 2.1MG/ML, SODIUM CHLORIDE 7.14MG/ML, SODIUM PHOSPHATE 0.42MG/ML · SOLUTION · IRRIGATION

Approval history

2008-07-24Type 3 - New Dosage Form · Original · standard — Review ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →